434 related articles for article (PubMed ID: 17230294)
21. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
22. Port-site implantation after laparoscopic treatment of borderline ovarian tumors.
Morice P; Camatte S; Larregain-Fournier D; Thoury A; Duvillard P; Castaigne D
Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1167-70. PubMed ID: 15516439
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
24. Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.
Kane A; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Fertil Steril; 2010 Dec; 94(7):2891-4. PubMed ID: 20537629
[TBL] [Abstract][Full Text] [Related]
25. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
26. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576
[TBL] [Abstract][Full Text] [Related]
27. Successful pregnancy after conservative surgery for stage IC ovarian cancer with serous borderline tumor on controlateral ovary: a case report.
Battaglia F; Plotti F; Zullo MA; Panici PB; Plotti G
Gynecol Oncol; 2006 Mar; 100(3):612-4. PubMed ID: 16249017
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study.
Palomba S; Zupi E; Russo T; Falbo A; Del Negro S; Manguso F; Marconi D; Tolino A; Zullo F
Hum Reprod; 2007 Feb; 22(2):578-85. PubMed ID: 17050549
[TBL] [Abstract][Full Text] [Related]
29. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
30. [Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours].
Fortin A; Hazout A; Thoury A; Alvès K; Bats AS; Dhainaut C; Madelenat P
Gynecol Obstet Fertil; 2005; 33(7-8):488-97. PubMed ID: 16019249
[TBL] [Abstract][Full Text] [Related]
31. [Laparoscopic treatment of borderline ovarian tumor: analysis of 54 patients and clinical outcomes].
Camatte S; Deffieux X; Castaigne D; Thoury A; Fourchotte V; Pautier P; Lhommé C; Duvillard P; Morice P
Gynecol Obstet Fertil; 2005 Jun; 33(6):395-402. PubMed ID: 15927503
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
33. [Borderline ovarian tumors: an update].
Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
[TBL] [Abstract][Full Text] [Related]
34. Borderline ovarian tumors and fertility.
Nam JH
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):227-34. PubMed ID: 20386444
[TBL] [Abstract][Full Text] [Related]
35. Fertility-sparing surgery for ovarian low malignant potential tumors.
Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
[TBL] [Abstract][Full Text] [Related]
36. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
37. Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience.
Kanat-Pektas M; Ozat M; Gungor T; Dikici T; Yilmaz B; Mollamahmutoglu L
Arch Gynecol Obstet; 2011 Nov; 284(5):1253-8. PubMed ID: 21170543
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors and reproductive outcomes of borderline ovarian tumors: a review of 186 patients].
Tao T; Cao DY; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Guo LN; Shen K
Zhonghua Yi Xue Za Zhi; 2010 May; 90(19):1304-8. PubMed ID: 20646576
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors.
Zanetta G; Rota S; Lissoni A; Meni A; Brancatelli G; Buda A
Gynecol Oncol; 2001 Apr; 81(1):63-6. PubMed ID: 11277651
[TBL] [Abstract][Full Text] [Related]
40. [Conservative management of malignant and borderline ovarian tumor].
Morice P; Camatte S; Wickart-Poque F; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Bull Cancer; 2002 Dec; 89(12):1019-26. PubMed ID: 12525360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
